Journal
Neuroimage: Clinical
Publication Date
1-1-2024
Volume
41
First Page
103551
Document Type
Open Access Publication
DOI
10.1016/j.nicl.2023.103551
Rights and Permissions
Chen G, McKay NS, Gordon BA, Liu J, Joseph-Mathurin N, Schindler SE, Hassenstab J, Aschenbrenner AJ, Wang Q, Schultz SA, Su Y, LaMontagne PJ, Keefe SJ, Massoumzadeh P, Cruchaga C, Xiong C, Morris JC, Benzinger TLS. Predicting cognitive decline: Which is more useful, baseline amyloid levels or longitudinal change? Neuroimage Clin. 2024;41:103551. doi: 10.1016/j.nicl.2023.103551. © 2023 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
Recommended Citation
Chen, Gengsheng; McKay, Nicole S; Gordon, Brian A; Liu, Jingxia; Joseph-Mathurin, Nelly; Schindler, Suzanne E; Hassenstab, Jason; Aschenbrenner, Andrew J; Wang, Qing; Schultz, Stephanie A; Su, Yi; LaMontagne, Pamela J; Keefe, Sarah J; Massoumzadeh, Parinaz; Cruchaga, Carlos; Xiong, Chengjie; Morris, John C; and Benzinger, Tammie L S, "Predicting cognitive decline: Which is more useful, baseline amyloid levels or longitudinal change?." Neuroimage: Clinical. 41, 103551 (2024).
https://digitalcommons.wustl.edu/oa_4/4369
Department
ICTS (Institute of Clinical and Translational Sciences)
Additional Links
Supplemental material is available for this article at publisher site.
